Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery and Intraperitoneal Chemohyperthermia

Sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Study ID
NCT00180960
Phase
PHASE2
Status
Terminated

Conditions

  • Appendix Tumors
  • Colon Tumors
  • Endocrine Tumors
  • Peritoneum Tumors
  • Rectum Tumors

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

The purpose of this study is to evaluate the treatment of a cancerous disease of the peritoneum with complete cytoreductive surgery with intraperitoneal chemohyperthermia using oxaliplatin plus irinotecan. This is a Phase II study with 100 patients. Origins of the tumors: these include colon, rectum, appendix, peritoneum, and endocrine tumors.

Key Dates

Start date
Jun 30, 2003
Status verified
Sep 2006

Study Design

Enrollment
100 participants
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Primary Outcome Measure

To study overall survival

Related Studies